February 5, 2026: Implementation of provincial high-sensitivity troponin assays and clinical pathways in rural areas

Group Photo Of Professional Colleagues Working Together In Clinical Analysis Laboratory
Clinical Chemist Working
Clinical Chemist Group
Clinical Chemist in Lab
Clinical Chemist in Lab
Clinical Chemist Group
Clinical Chemist Working on Computer
Clinical Chemist in Lab

Current Status

Not Enrolled

Price

Free

Get Started

Speakers: (1) Dr. Albert Tsui is a clinical biochemist at Alberta Precision Laboratories (APL) and Associate Professor at the Department of Laboratory Medicine and Pathology at the University of Alberta since 2017. He is the provincial pre-analytic section chief and provides oversight to high volume core chemistry laboratory in Edmonton hospitals at APL. He completed his PhD in Physiology at University of Toronto, and the post-doctoral clinical biochemistry fellowship at University of Alberta. His service and research interest includes pre-analytic, quality improvement, and biomarker translation in cardiovascular disease, critical care, neurology, and diabetes.

(2) Dr. Heather Paul

Overview: This presentation will describe the provincial implementation of high sensitivity troponin assays and clinical pathways in Alberta. The role of the laboratory in close collaboration with emergency department, cardiology, and leadership will be described. Rural area and point-of-care implementation and challenges will be discussed.
Learning Objectives: At the conclusion of this session, participants will be able to:
1) Describe the role of laboratory in rolling out new high sensitivity troponin assays.
2) Identify the unique perspectives of implementing hs-cTn assay and clinical pathway in rural and point-of-care settings.

Course Content

Watch Webcast (Feb 5, 2026)